Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles, Journal of Virology, vol.76, issue.14, pp.6919-6928, 2002. ,
DOI : 10.1128/JVI.76.14.6919-6928.2002
Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection, Journal of Virology, vol.82, issue.12, pp.5715-5724, 2008. ,
DOI : 10.1128/JVI.02530-07
Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies, Journal of Hepatology, vol.54, issue.3, pp.566-576, 2011. ,
DOI : 10.1016/j.jhep.2010.10.014
URL : https://hal.archives-ouvertes.fr/inserm-00701487
Low pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus Particles, Journal of Biological Chemistry, vol.284, issue.26 ,
DOI : 10.1074/jbc.M109.014647
Initiation of Hepatitis C Virus Infection Is Dependent on Cholesterol and Cooperativity between CD81 and Scavenger Receptor B Type I, Journal of Virology, vol.81, issue.1, pp.374-383, 2007. ,
DOI : 10.1128/JVI.01134-06
Assembly of infectious hepatitis C virus particles, Trends in Microbiology, vol.19, issue.2, pp.95-103, 2011. ,
DOI : 10.1016/j.tim.2010.11.005
Identification of the Niemann-Pick C1???like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor, Nature Medicine, vol.18, issue.2, 2012. ,
DOI : 10.1016/S0002-9440(10)63352-4
Niemann-Pick C1-Like 1 (NPC1L1) Protein in Intestinal and Hepatic Cholesterol Transport, Annual Review of Physiology, vol.73, issue.1, pp.239-259, 2011. ,
DOI : 10.1146/annurev-physiol-012110-142233
Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy, Hepatology, vol.27, issue.3, pp.864-874, 2010. ,
DOI : 10.1002/hep.23787
Ezetimibe-associated adverse effects: what the clinician needs to know, International Journal of Clinical Practice, vol.84, issue.Suppl. A, pp.88-96, 2008. ,
DOI : 10.1111/j.1742-1241.2007.01592.x